Roberto Bugarini

4.5k total citations · 1 hit paper
44 papers, 2.4k citations indexed

About

Roberto Bugarini is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Roberto Bugarini has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Roberto Bugarini's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (10 papers) and Influenza Virus Research Studies (8 papers). Roberto Bugarini is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (10 papers) and Influenza Virus Research Studies (8 papers). Roberto Bugarini collaborates with scholars based in Italy, United States and United Kingdom. Roberto Bugarini's co-authors include Audino Podda, Frederick L. Baehner, Steven Shak, Janine Salter, Mitch Dowsett, Iain Stephenson, Maria Zambon, Karl G. Nicholson, Emma M. Quinn and Elizabeth A. Mallon and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Roberto Bugarini

41 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

2010 546 citations Roberto Bugarini, Frederick L. Baehner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Bugarini Italy	23	817	649	626	599	377	44	2.4k
Sophie Prévôt France	26	852 1.0×	457 0.7×	224 0.4×	294 0.5×	341 0.9×	66	3.1k
Juan Carlos García‐Ruiz Spain	27	447 0.5×	347 0.5×	440 0.7×	210 0.4×	274 0.7×	105	1.8k
Agostino Riva Italy	30	512 0.6×	661 1.0×	817 1.3×	174 0.3×	372 1.0×	122	3.0k
Rajesh Kannangai India	23	956 1.2×	343 0.5×	534 0.9×	257 0.4×	232 0.6×	134	2.5k
Jean‐Marie Andrieu France	28	511 0.6×	566 0.9×	586 0.9×	133 0.2×	308 0.8×	89	2.8k
Steven A. Miles United States	23	647 0.8×	997 1.5×	872 1.4×	95 0.2×	405 1.1×	50	2.9k
Patrick Haslett United States	32	785 1.0×	831 1.3×	841 1.3×	130 0.2×	348 0.9×	57	4.3k
Angela Battistini Italy	32	460 0.6×	822 1.3×	343 0.5×	280 0.5×	93 0.2×	114	3.2k
Giuseppe Colucci Italy	35	1.5k 1.9×	1.3k 2.0×	241 0.4×	402 0.7×	286 0.8×	152	3.7k
Pierre‐Simon Rohrlich France	33	658 0.8×	670 1.0×	462 0.7×	169 0.3×	270 0.7×	138	3.5k

Countries citing papers authored by Roberto Bugarini

Since Specialization

Citations

This map shows the geographic impact of Roberto Bugarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bugarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bugarini more than expected).

Fields of papers citing papers by Roberto Bugarini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Bugarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bugarini. The network helps show where Roberto Bugarini may publish in the future.

Co-authorship network of co-authors of Roberto Bugarini

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Bugarini. A scholar is included among the top collaborators of Roberto Bugarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Bugarini. Roberto Bugarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giles, Michelle, Carmen Baccarini, Paul Nguyen, et al.. (2025). Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study. EClinicalMedicine. 87. 103428–103428.

Ho, Nhan Thi, Steven G. Hughes, Rose E. Sekulovich, et al.. (2024). A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines. npj Vaccines. 9(1). 233–233. 4 indexed citations

Harrison, Simon J., Andy Hsu, Paul J. Neeson, et al.. (2013). Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant. Leukemia & lymphoma. 55(5). 1053–1060. 6 indexed citations

Sparano, Joseph A., Lori J. Goldstein, Barrett H. Childs, et al.. (2011). Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer. Clinical Cancer Research. 17(22). 7194–7203. 20 indexed citations

Toschi, Elena, Cecilia Sgadari, Ilaria Bacigalupo, et al.. (2010). Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome‐independent block of angiogenesis and matrix metalloproteinases. International Journal of Cancer. 128(1). 82–93. 43 indexed citations

Sparano, Joseph A., Lori J. Goldstein, Barrett H. Childs, et al.. (2009). Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clinical Cancer Research. 15(24). 7693–7700. 21 indexed citations

Ambrozaitis, Arvydas, et al.. (2009). A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine. Vaccine. 27(43). 6022–6029. 29 indexed citations

Groth, Nicola, Roberto Bugarini, Maria Lattanzi, et al.. (2009). Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture. The Journal of Infectious Diseases. 200(6). 841–848. 62 indexed citations

Groth, Nicola, Emanuele Montomoli, Cosimo Gentile, et al.. (2008). Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial. Vaccine. 27(5). 786–791. 36 indexed citations

10.

Nemes, Elisa, Enrico Lugli, Milena Nasi, et al.. (2006). Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. AIDS. 20(16). 2021–2032. 20 indexed citations

11.

Nasi, Milena, Marcello Pinti, Roberto Bugarini, et al.. (2005). Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients. Immunogenetics. 57(9). 628–635. 38 indexed citations

12.

Stephenson, Iain, Roberto Bugarini, Karl G. Nicholson, et al.. (2005). Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy. The Journal of Infectious Diseases. 191(8). 1210–1215. 228 indexed citations

13.

Mussini, Cristina, Marcello Pinti, Roberto Bugarini, et al.. (2005). Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study. AIDS. 19(15). 1627–1633. 59 indexed citations

14.

Cossarizza, Andrea, Fabrizio Poccia, Chiara Agrati, et al.. (2004). Highly Active Antiretroviral Therapy Restores CD4+ V?? T-Cell Repertoire in Patients With Primary Acute HIV Infection But Not in Treatment-Naive HIV+ Patients With Severe Chronic Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(3). 213–222. 26 indexed citations

15.

Giovannetti, Antonello, Marina Pierdominici, Marco Marziali, et al.. (2003). Persistently Biased T-Cell Receptor Repertoires in HIV-1-Infected Combination Antiretroviral Therapy???Treated Patients Despite Sustained Suppression of Viral Replication. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(2). 140–154. 20 indexed citations

16.

Fiore, J R, Barbara Suligoi, Annalisa Saracino, et al.. (2003). Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 17(15). 2169–2176. 91 indexed citations

17.

Iorio, Anna Maria, Daniela Francisci, Barbara Camilloni, et al.. (2003). Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. Vaccine. 21(25-26). 3629–3637. 58 indexed citations

18.

Ascherl, Gudrun, Cecilia Sgadari, Roberto Bugarini, et al.. (2001). Serum Concentrations of Fibroblast Growth Factor 2 Are Increased in HIV Type 1-Infected Patients and Inversely Related to Survival Probability. AIDS Research and Human Retroviruses. 17(11). 1035–1039. 23 indexed citations

19.

Suligoi, Barbara, et al.. (2001). Prevalence and Risk Factors for Herpes Simplex Virus Type 2 Infection Among Adolescents and Adults in Northern Cameroon. Sexually Transmitted Diseases. 28(12). 690–693. 13 indexed citations

20.

Rezza, Giovanni, Massimo Andreoni, Roberto Bugarini, et al.. (2000). Prevalence and Risk Factors for Human Herpesvirus 8 Infection in Northern Cameroon. Sexually Transmitted Diseases. 27(3). 159–164. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact